Hikal Share Price

Hikal Share Price

NSE: HIKAL | BSE: 524735 | Pharmaceuticals

100% Buy

₹403.90

-₹0.85 (-0.21%) Last updated on 20 May, 2025 | 15:29 IST

Hikal Overview

Market cap
Market Cap Switch₹4,991 Crs
Open
₹405.90
Prev. Close
₹404.75
Circuit range
₹485.70 - ₹323.80
Day range
₹400.25 - ₹414.40
Year range
₹267.25 - ₹464.75
Volume
3,88,475
Avg. traded
₹406.89
Revenue (12m)
₹1,860 Crs

About Hikal

Hikal Limited is a Mumbai-based chemicals company. It specialises in research, development and manufacturing of fine chemicals, agrochemicals and pharmaceutical intermediates.

In 1988, the company started manufacturing and selling chemicals, intermediates, medicines and insecticides. Hikal Chemical Industries Limited (HCIL) was a joint venture between the Hiremath family and Surajmukhi Investment and Finance Limited, a fully-owned subsidiary of Kalyani Steels Limited.

Hikal Limited became a full-fledged public limited company in 1994. The year 2000 saw the rebranding of Hikal Chemical Industries Ltd to Hikal Ltd. The company's plan to diversify into agrochemicals, pharmaceuticals and biotech is reflected in the name change. In 2005, Hikal Ltd and Crompton Corporation USA signed a long-term agreement to produce and supply a next-generation crop protection product.

In 2008, the company founded Acoris Research Ltd., a fully operational contract research facility situated at the International Biotech Park Pune. A year later in 2009, the company enhanced its manufacturing capabilities. The construction of a new multi-purpose plant for active ingredients in crop protection at the Taloja site, in Maharashtra, was successfully concluded. It commissioned several new multipurpose Active Pharmaceutical Ingredient (API) plants in Bangalore, which holds approval from the US Food and Drug Administration (FDA). A new multipurpose pharmaceutical intermediates plant was established in Panoli, Gujarat.

The market capitalisation of Hikal Limited is over ₹3,700 crore as of January 11, 2024. Hikal share price has gained over 70% in the last three years.

Business operations

Hikal’s business is divided into two segments – crop protection and pharmaceuticals, with a broad portfolio of goods and services to meet the client's changing demands. In its crop protection segment, the company combines research and technology, production skills and intellectual capital to deliver top-notch crop protection products, including insecticides, fungicides, herbicides, biocides and intermediates.

Hikal Limited provides active pharmaceutical ingredients, active ingredients and intermediates to international clients. Its facilities are also designed to cater to the customised requirements of clients in the United States, Europe and Japan. There was a substantial increase in its global customers in 2023 after the introduction of new products within the antidiabetic therapeutic category.

The crop protection division experienced a 12% annual revenue growth, reaching a total revenue of ₹907.9 crore in FY23. The pharmaceutical division reported revenues amounting to ₹1,115 crore during the same period.

The company operates five manufacturing facilities across India situated in Taloja and Mahad in Maharashtra, Panoli in Gujarat and Jigani in Karnataka. It also runs a research & technology centre in Maharashtra’s Pune. These facilities undergo regular inspections by multinational corporations and global regulatory authorities. Hikal's R&D has a comprehensive infrastructure that includes 11 synthetic laboratories, four analytical labs and one process intensification lab.

Financial highlights

– Hikal Limited's revenue from operations for FY23 stood at ₹2,023 crore, up by 4% compared to ₹1,943 crore in FY22.

– EBITDA (earnings before interest, taxes, depreciation, and amortisation) decreased to ₹262.5 crore as against ₹345.4 crore for the previous year, a decline of 24%.

– Hinal Limited’s profit after tax (PAT) of the company decreased to ₹78.4 crore as against ₹160.5 crore for the previous year, a decline of 51%.

— The earnings per share (EPS) for FY23 was ₹6.36 compared to ₹13.02 in the previous financial year.

  • Chart
  • Fundamentals
  • Financials
  • Shareholdings
  • Events
  • Peers
  • News
  • FAQs

Hikal Share Price Chart

Please wait...

Hikal Key Indicators

P/E ratio
38.04
P/B ratio
4.02
ROE
5.99%
ROCE
7.82%
Dividend yield
0.3%
Debt/Equity ratio
0.69
EPS
5.64

Investment Checklist: (2/6)

passed

Equity returns

not passed

Dividend returns

not passed

Safety factor

NA

Growth factor

passed

Debt vs Equity

NA

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst Ratings:

Buy

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Hikal Financial Ratios

  • Profitability

  • Operational

  • Valuation

Operating profit margin

15.1%

Net profit margin

3.9%

ROE

5.99%

ROA

2.85%

ROCE

7.82%

Hikal Shareholder returns

1 day
+4.14%
1 week
+1.53%
1 month
-6.22%
3 months
+15.43%
1 year
+35.55%
3 years
+5.60%
5 years
+253.49%

Revenue Statement

All values are in ₹ Crores (Cr)
RevenueNo Sort
Operating ProfitNo Sort
Net ProfitNo Sort
Mar-24
1,784.60
269.48
69.60
Mar-23
2,023.03
262.48
78.38
Mar-22
1,942.72
345.45
160.50
Mar-21
1,720.44
327.87
133.14

Cash Flow

All values are in ₹ Crores (Cr)
OperatingNo Sort
InvestingNo Sort
FinancingNo Sort
Mar-24
186.72
-173.75
-27.00
Mar-23
315.31
-292.34
-7.68
Mar-22
293.73
-284.37
-5.56
Mar-21
229.02
-156.2
-96.87

Balance Sheet

All values are in ₹ Crores (Cr)
Total AssetNo Sort
Total LiabilityNo Sort
Mar-24
2,487.15
1,299.49
Mar-23
2,385.48
1,252.01
Mar-22
2,328.03
1,260.05
Mar-21
2,015.70
1,082.30

Hikal Share Price History

DayOpenCloseChange %
19-May-25
₹385.30
₹404.75
+4.14%
16-May-25
₹395.45
₹388.65
-0.96%
15-May-25
₹395.00
₹392.40
-6.90%
14-May-25
₹411.70
₹421.50
+3.41%
13-May-25
₹401.00
₹407.60
+2.25%
12-May-25
₹393.30
₹398.65
+3.01%
09-May-25
₹381.00
₹387.00
+1.61%
08-May-25
₹390.20
₹380.85
-1.89%

Hikal Shareholding Pattern

Promoters (68.85%)

Mutual Funds (2.92%)

Retail and other (21.61%)

Foreign institutions-FII (6.06%)

Other domestic institutions (0.56%)

Promoters

Corporate Actions

  • Dividend • ₹0.6/share

    Ex date 07 Feb 2025

    expand tab
  • Dividend • ₹0.6/share

    Ex date 04 Sep 2024

    expand tab
  • Dividend • ₹0.6/share

    Ex date 20 Feb 2024

    expand tab
  • Dividend • ₹0.6/share

    Ex date 18 Sep 2023

    expand tab

Stocks Similar to Hikal

PriceNo Sort
Change %No Sort
Aarti Drugs₹469.20-₹11.40 (-2.37%)
AstraZeneca Pharma Ind₹7,907.00-₹74.50 (-0.93%)
Caplin Point Lab₹2,134.50-₹26.60 (-1.23%)
FDC Limited₹455.25+₹4.60 (1.02%)
Glenmark Life Science₹1,112.00-₹32.50 (-2.84%)
Granules India₹510.50-₹1.20 (-0.23%)
Jubilant Ingrevia₹675.60-₹23.10 (-3.31%)
Procter & Gamble Health₹5,281.00+₹30.50 (0.58%)
Shilpa Medicare₹703.90-₹7.55 (-1.06%)

Popular Stocks

PriceNo Sort
Change %No Sort
HDFC Bank₹1,917.10-₹21.60 (-1.11%)
Indian Energy Exchange₹197.76+₹0.13 (0.07%)
Indian Railway Tourism Corp₹787.00-₹17.60 (-2.19%)
ITC₹435.40+₹0.05 (0.01%)
JIO FIN SERVICES LTD₹271.70-₹5.35 (-1.93%)
Reliance₹1,424.50-₹16.30 (-1.13%)
Tata Motors₹720.70-₹8.80 (-1.21%)
Tata Power₹399.65-₹8.45 (-2.07%)
Tata Steel₹159.59+₹2.02 (1.28%)
Wipro₹250.20-₹1.55 (-0.62%)

FAQs on Hikal

What is the share price of Hikal today?

chevron-up
Hikal share price is ₹ 403.90 as on 20 May, 2025 | 15:29 IST.

What are the high & low stock price of Hikal today?

chevron-up
Hikal stock price hit a high of ₹ 414.40 and low of ₹ 400.25 as on 20 May, 2025 | 15:29 IST.

What is the market cap of Hikal?

chevron-up
The market cap of Hikal is ₹ 4,990.60 Crores as on 20 May, 2025 | 15:29 IST.

What are the the 52-week high and low share prices of Hikal stock on the NSE?

chevron-up
52-week high stock Price of Hikal is ₹ 464.75 and Low Price is ₹ 267.25 as on 20 May, 2025 | 15:29 IST.

What are the stock symbols of Hikal?

chevron-up
The stock symbol of Hikal is NSE: HIKAL on the NSE and BSE: 524735 on the BSE, and the ISIN is INE475B01022.

Can I buy Hikal shares on Holidays?

chevron-up
No, shares of Hikal or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Hikal shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

What is the PE and PB ratio of Hikal?

chevron-up
The PE and PB ratio of Hikal is 38.04 and 4.02 respectively, as on 20 May, 2025 | 15:29 IST.

What are the returns on Hikal shares?

chevron-up
The historical returns for Hikal shares are 35.55 for 1 year, 5.6 for 3 year and 253.49 for 5 year.